Invesco
LUNG icon

Invesco’s Pulmonx LUNG Stock Holding History

Invesco’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,318
Closed -$13.3K – 3891
2026
Q1 		$13.3K Sell
10,318
-255
-2% -$421 ﹤0.01% 3731
2025
Q4 		$23.4K Buy
10,573
+42
+0.4% +$79 ﹤0.01% 3737
2025
Q3 		$17.1K Buy
10,531
+3
+0% +$6 ﹤0.01% 3778
2025
Q2 		$27.3K Sell
10,528
-170
-2% -$671 ﹤0.01% 3752
2025
Q1 		$72K Sell
10,698
-816
-7% -$5.78K ﹤0.01% 3666
2024
Q4 		$78.2K Buy
11,514
+326
+3% +$2.15K ﹤0.01% 3654
2024
Q3 		$92.7K Buy
11,188
+655
+6% +$4.74K ﹤0.01% 3629
2024
Q2 		$66.8K Sell
10,533
-1,132
-10% -$8.7K ﹤0.01% 3794
2024
Q1 		$108K Sell
11,665
-13,973
-55% -$164K ﹤0.01% 3731
2023
Q4 		$327K Sell
25,638
-4,533
-15% -$47.2K ﹤0.01% 3405
2023
Q3 		$312K Buy
30,171
+16,445
+120% +$190K ﹤0.01% 3438
2023
Q2 		$180K Sell
13,726
-161,093
-92% -$1.97M ﹤0.01% 3639
2023
Q1 		$1.95M Buy
174,819
+162,450
+1,313% +$1.6M ﹤0.01% 2640
2022
Q4 		$104K Sell
12,369
-1,455
-11% -$13.8K ﹤0.01% 3815
2022
Q3 		$230K Buy
13,824
+1,785
+15% +$32.9K ﹤0.01% 3630
2022
Q2 		$178K Buy
12,039
+1,447
+14% +$29.8K ﹤0.01% 3759
2022
Q1 		$262K Sell
10,592
-201
-2% -$5.19K ﹤0.01% 3689
2021
Q4 		$346K Sell
10,793
-1,022
-9% -$37.3K ﹤0.01% 3550
2021
Q3 		$426K Sell
11,815
-160,709
-93% -$6.32M ﹤0.01% 3501
2021
Q2 		$7.61M Sell
172,524
-14,871
-8% -$648K ﹤0.01% 2223
2021
Q1 		$8.57M Sell
187,395
-63,378
-25% -$3.64M ﹤0.01% 2049
2020
Q4 		$17.3M Buy
+250,773
New +$12.3M 0.01% 1510

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Invesco's LUNG Position: Q2 2026 in Review

Invesco sold out of Pulmonx (LUNG) in Q2 2026, closing a stake of 10,318 shares — an estimated $13.3K sold.

Invesco first reported a position in LUNG in Q4 2020 and held it in 22 quarters. The position peaked at $17.3M in Q4 2020. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Invesco reported no remaining Pulmonx position as of Q2 2026 after selling out during the quarter.
  • Invesco sold 10,318 Pulmonx shares in Q2 2026, an estimated $13.3K.
  • Invesco first reported a position in Pulmonx in Q4 2020 and held it in 22 quarters.
  • Invesco's Pulmonx position peaked at $17.3M in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.